<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03270852</url>
  </required_header>
  <id_info>
    <org_study_id>chhwang8</org_study_id>
    <nct_id>NCT03270852</nct_id>
  </id_info>
  <brief_title>Enhanced Reality for Hemiparetic Arm in the Stroke Patients</brief_title>
  <official_title>Enhanced Reality for Hemiparetic Arm in the Stroke Patients; Randomized Case-controlled Clinical Trial for Efficacy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ulsan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ulsan University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The researchers found that enhanced reality developed for the first time in the word by us
      had a synergistic or additive effect on brain plasticity in patients without central nervous
      system injury. The aim of this study is to determine the validity and feasibility of enhanced
      reality in hemiparetic arm in the stroke patients with central nervous system injury.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pre-interventional evaluation; within 1 day of initiation of the intervention; 10 days after
      initiation of the intervention; 30 days after termination of treatment.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2018</start_date>
  <completion_date type="Anticipated">October 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of Jebsen Taylor test</measure>
    <time_frame>1 day before the initiation of intervention, 10 day after the initiation of intervention, and 30 days after termination of treatment</time_frame>
    <description>Jebsen-Taylor Hand Function Test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of Arm motor Fugl-Mayer scale</measure>
    <time_frame>1 day before the initiation of intervention, 10 day after the initiation of intervention, and 30 days after termination of treatment</time_frame>
    <description>Arm motor Fugl-Mayer scale; wrist &amp; hand/proximal arm</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change of Ashworth scale</measure>
    <time_frame>1 day before the initiation of intervention, 10 day after the initiation of intervention, and 30 days after termination of treatment</time_frame>
    <description>Ashworth scale; wrist/ elbow</description>
  </other_outcome>
  <other_outcome>
    <measure>Change of 9-hole pegboard</measure>
    <time_frame>1 day before the initiation of intervention, 10 day after the initiation of intervention, and 30 days after termination of treatment</time_frame>
    <description>9-hole pegboard</description>
  </other_outcome>
  <other_outcome>
    <measure>Change of Stroke impact scale</measure>
    <time_frame>1 day before the initiation of intervention, 10 day after the initiation of intervention, and 30 days after termination of treatment</time_frame>
    <description>Stroke impact scale, hand function</description>
  </other_outcome>
  <other_outcome>
    <measure>Change of Grasp force in Newtons</measure>
    <time_frame>1 day before the initiation of intervention, 10 day after the initiation of intervention, and 30 days after termination of treatment</time_frame>
    <description>Grasp force in Newtons</description>
  </other_outcome>
  <other_outcome>
    <measure>Change of Active range of motion of wrist joint</measure>
    <time_frame>1 day before the initiation of intervention, 10 day after the initiation of intervention, and 30 days after termination of treatment</time_frame>
    <description>range of motion of the wrist joint</description>
  </other_outcome>
  <other_outcome>
    <measure>Change of Korean-modified Barthel index</measure>
    <time_frame>1 day before the initiation of intervention, 10 day after the initiation of intervention, and 30 days after termination of treatment</time_frame>
    <description>Korean version-Modified Barthel Index</description>
  </other_outcome>
  <other_outcome>
    <measure>Change of motor evoked potential of abdutor pollicis brevis</measure>
    <time_frame>1 day before the initiation of intervention, 10 day after the initiation of intervention, and 30 days after termination of treatment</time_frame>
    <description>Motor Evoked Potential</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">38</enrollment>
  <condition>Stroke</condition>
  <condition>Paresis</condition>
  <condition>Mirror Movement</condition>
  <arm_group>
    <arm_group_label>Enhanced reality</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients are provided with occupational therapy and physical therapy (task-oriented OT 30 min, FES 20 min) daily for 50 minutes.
ER therapy is provided 2 times a day for 10 minutes for 2 weeks (10 days of treatment week), except for time of installation, calibration, and 3 minute breaks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Enhanced reality</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients are provided with occupational therapy and physical therapy (task-oriented OT 30 min, FES 20 min) daily for 50 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Enhanced reality</intervention_name>
    <description>This prototype is developed by investigators for the first time so that it have no trademark or manufacturer name yet.
The patient sits facing the horizontal desk with the ER therapy device, and then raises the wrist joint to the fixed base. The hand, wrist, and distal forearm to be treated are positioned below the ER medical camera so that the wrist is visible on the screen. Fix the wrist and wrist joint using Velcro. When treating the distal forearm, detach the wrist fixing Velcro.</description>
    <arm_group_label>Enhanced reality</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No Enhanced reality</intervention_name>
    <description>Identical rehabilitation without enhanced reality</description>
    <arm_group_label>No Enhanced reality</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Arm motor Fugl-Mayer scale; wrist/hand subscales ≥ 2-20

          -  9-hole pegboard ; ≥ 25% of contra-lateral hand

        Exclusion Criteria:

          -  Alexander apraxia scale ≤2

          -  NIH stroke scale question Ia-c ≥1

          -  Nottingham sensory scale; &lt;75% of contra-lateral hand

          -  Ashworth scale ≥3

          -  NIH stroke scale question IX ≥2

          -  Beck depression inventory ≥21

          -  Significant upper extremity disease causing hand or below elbow dysfunction

          -  Visual disturbance

          -  Refusal of participation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chang Ho Hwang, M.D., Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Ulsan University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chang Ho Hwang</last_name>
    <phone>+82-52-250-7210</phone>
    <email>chhwang1220ciba@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ulsan University Hospital</name>
      <address>
        <city>Ulsan</city>
        <zip>682-714</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2017</study_first_submitted>
  <study_first_submitted_qc>August 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 1, 2017</study_first_posted>
  <last_update_submitted>May 1, 2018</last_update_submitted>
  <last_update_submitted_qc>May 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ulsan University Hospital</investigator_affiliation>
    <investigator_full_name>Chang Ho Hwang</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Paresis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

